Cargando…

1-methylnicotinamide and its structural analog 1,4-dimethylpyridine for the prevention of cancer metastasis

BACKGROUND: 1-methylnicotinamide (1-MNA), an endogenous metabolite of nicotinamide, has recently gained interest due to its anti-inflammatory and anti-thrombotic activities linked to the COX-2/PGI(2) pathway. Given the previously reported anti-metastatic activity of prostacyclin (PGI(2)), we aimed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Blazejczyk, Agnieszka, Switalska, Marta, Chlopicki, Stefan, Marcinek, Andrzej, Gebicki, Jerzy, Nowak, Marcin, Nasulewicz-Goldeman, Anna, Wietrzyk, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944260/
https://www.ncbi.nlm.nih.gov/pubmed/27412454
http://dx.doi.org/10.1186/s13046-016-0389-9
_version_ 1782442739781074944
author Blazejczyk, Agnieszka
Switalska, Marta
Chlopicki, Stefan
Marcinek, Andrzej
Gebicki, Jerzy
Nowak, Marcin
Nasulewicz-Goldeman, Anna
Wietrzyk, Joanna
author_facet Blazejczyk, Agnieszka
Switalska, Marta
Chlopicki, Stefan
Marcinek, Andrzej
Gebicki, Jerzy
Nowak, Marcin
Nasulewicz-Goldeman, Anna
Wietrzyk, Joanna
author_sort Blazejczyk, Agnieszka
collection PubMed
description BACKGROUND: 1-methylnicotinamide (1-MNA), an endogenous metabolite of nicotinamide, has recently gained interest due to its anti-inflammatory and anti-thrombotic activities linked to the COX-2/PGI(2) pathway. Given the previously reported anti-metastatic activity of prostacyclin (PGI(2)), we aimed to assess the effects of 1-MNA and its structurally related analog, 1,4-dimethylpyridine (1,4-DMP), in the prevention of cancer metastasis. METHODS: All the studies on the anti-tumor and anti-metastatic activity of 1-MNA and 1,4-DMP were conducted using the model of murine mammary gland cancer (4T1) transplanted either orthotopically or intravenously into female BALB/c mouse. Additionally, the effect of the investigated molecules on cancer cell-induced angiogenesis was estimated using the matrigel plug assay utilizing 4T1 cells as a source of pro-angiogenic factors. RESULTS: Neither 1-MNA nor 1,4-DMP, when given in a monotherapy of metastatic cancer, influenced the growth of 4T1 primary tumors transplanted orthotopically; however, both compounds tended to inhibit 4T1 metastases formation in lungs of mice that were orthotopically or intravenously inoculated with 4T1 or 4T1-luc2-tdTomato cells, respectively. Additionally, while 1-MNA enhanced tumor vasculature formation and markedly increased PGI(2) generation, 1,4-DMP did not have such an effect. The anti-metastatic activity of 1-MNA and 1,4-DMP was further confirmed when both agents were applied with a cytostatic drug in a combined treatment of 4T1 murine mammary gland cancer what resulted in up to 80 % diminution of lung metastases formation. CONCLUSIONS: The results of the studies presented below indicate that 1-MNA and its structural analog 1,4-DMP prevent metastasis and might be beneficially implemented into the treatment of metastatic breast cancer to ensure a comprehensive strategy of metastasis control. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13046-016-0389-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4944260
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49442602016-07-15 1-methylnicotinamide and its structural analog 1,4-dimethylpyridine for the prevention of cancer metastasis Blazejczyk, Agnieszka Switalska, Marta Chlopicki, Stefan Marcinek, Andrzej Gebicki, Jerzy Nowak, Marcin Nasulewicz-Goldeman, Anna Wietrzyk, Joanna J Exp Clin Cancer Res Research BACKGROUND: 1-methylnicotinamide (1-MNA), an endogenous metabolite of nicotinamide, has recently gained interest due to its anti-inflammatory and anti-thrombotic activities linked to the COX-2/PGI(2) pathway. Given the previously reported anti-metastatic activity of prostacyclin (PGI(2)), we aimed to assess the effects of 1-MNA and its structurally related analog, 1,4-dimethylpyridine (1,4-DMP), in the prevention of cancer metastasis. METHODS: All the studies on the anti-tumor and anti-metastatic activity of 1-MNA and 1,4-DMP were conducted using the model of murine mammary gland cancer (4T1) transplanted either orthotopically or intravenously into female BALB/c mouse. Additionally, the effect of the investigated molecules on cancer cell-induced angiogenesis was estimated using the matrigel plug assay utilizing 4T1 cells as a source of pro-angiogenic factors. RESULTS: Neither 1-MNA nor 1,4-DMP, when given in a monotherapy of metastatic cancer, influenced the growth of 4T1 primary tumors transplanted orthotopically; however, both compounds tended to inhibit 4T1 metastases formation in lungs of mice that were orthotopically or intravenously inoculated with 4T1 or 4T1-luc2-tdTomato cells, respectively. Additionally, while 1-MNA enhanced tumor vasculature formation and markedly increased PGI(2) generation, 1,4-DMP did not have such an effect. The anti-metastatic activity of 1-MNA and 1,4-DMP was further confirmed when both agents were applied with a cytostatic drug in a combined treatment of 4T1 murine mammary gland cancer what resulted in up to 80 % diminution of lung metastases formation. CONCLUSIONS: The results of the studies presented below indicate that 1-MNA and its structural analog 1,4-DMP prevent metastasis and might be beneficially implemented into the treatment of metastatic breast cancer to ensure a comprehensive strategy of metastasis control. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13046-016-0389-9) contains supplementary material, which is available to authorized users. BioMed Central 2016-07-13 /pmc/articles/PMC4944260/ /pubmed/27412454 http://dx.doi.org/10.1186/s13046-016-0389-9 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Blazejczyk, Agnieszka
Switalska, Marta
Chlopicki, Stefan
Marcinek, Andrzej
Gebicki, Jerzy
Nowak, Marcin
Nasulewicz-Goldeman, Anna
Wietrzyk, Joanna
1-methylnicotinamide and its structural analog 1,4-dimethylpyridine for the prevention of cancer metastasis
title 1-methylnicotinamide and its structural analog 1,4-dimethylpyridine for the prevention of cancer metastasis
title_full 1-methylnicotinamide and its structural analog 1,4-dimethylpyridine for the prevention of cancer metastasis
title_fullStr 1-methylnicotinamide and its structural analog 1,4-dimethylpyridine for the prevention of cancer metastasis
title_full_unstemmed 1-methylnicotinamide and its structural analog 1,4-dimethylpyridine for the prevention of cancer metastasis
title_short 1-methylnicotinamide and its structural analog 1,4-dimethylpyridine for the prevention of cancer metastasis
title_sort 1-methylnicotinamide and its structural analog 1,4-dimethylpyridine for the prevention of cancer metastasis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944260/
https://www.ncbi.nlm.nih.gov/pubmed/27412454
http://dx.doi.org/10.1186/s13046-016-0389-9
work_keys_str_mv AT blazejczykagnieszka 1methylnicotinamideanditsstructuralanalog14dimethylpyridineforthepreventionofcancermetastasis
AT switalskamarta 1methylnicotinamideanditsstructuralanalog14dimethylpyridineforthepreventionofcancermetastasis
AT chlopickistefan 1methylnicotinamideanditsstructuralanalog14dimethylpyridineforthepreventionofcancermetastasis
AT marcinekandrzej 1methylnicotinamideanditsstructuralanalog14dimethylpyridineforthepreventionofcancermetastasis
AT gebickijerzy 1methylnicotinamideanditsstructuralanalog14dimethylpyridineforthepreventionofcancermetastasis
AT nowakmarcin 1methylnicotinamideanditsstructuralanalog14dimethylpyridineforthepreventionofcancermetastasis
AT nasulewiczgoldemananna 1methylnicotinamideanditsstructuralanalog14dimethylpyridineforthepreventionofcancermetastasis
AT wietrzykjoanna 1methylnicotinamideanditsstructuralanalog14dimethylpyridineforthepreventionofcancermetastasis